News | EP Mapping and Imaging Systems | May 09, 2019

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment

Philips’ integrated solution will combine its KODEX-EPD dielectric imaging and navigation system to support cryoablation procedures performed with Medtronic Arctic Front Advance cryoablation technology

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment

May 9, 2019 — Philips announced a collaboration with Medtronic to further advance treatment of paroxysmal atrial fibrillation (PAF), a common heart rhythm disorder. Through the agreement, Medtronic will facilitate sales of products on behalf of Philips to provide an integrated image guidance solution for cryoablation procedures. Philips will bring to market the novel KODEX-EPD cardiac imaging and navigation system with cryoablation specific features to enable electrophysiologists to perform cryoablation procedures with reduced need for X-ray imaging.

Atrial fibrillation (AF) affects more than 33 million people worldwide.[1] Cryoballoon ablation is used in a minimally invasive procedure to isolate the pulmonary veins, which are a source of erratic electrical signals that cause AF. The technology uses cold energy rather than heat (radiofrequency [RF] ablation) to create scar tissue and interrupt these irregular electrical pathways in the heart.

Philips’ KODEX-EPD system uses dielectric imaging to create computed tomography (CT)-like 3-D, high-definition images of a patient’s cardiac structures in real time.[2] Dielectric imaging offers many benefits in comparison to current approaches, for both cryo and RF ablation procedures. The technology provides real-time 3-D imaging, reducing the need for X-ray imaging. It also has mapping capabilities without the need to reset a reference point if the patient moves. As a result, the KODEX-EPD system provides excellent visualization and simplifies navigation, enhancing procedure efficiency and patient care, according to Philips.

In pulmonary vein isolation (PVI) cryoablation procedures, the system confirms the positioning of the Medtronic Achieve Mapping Catheter, supporting quick visualization of the pulmonary veins. Philips is also developing balloon visualization capabilities for the KODEX-EPD system.

KODEX-EPD is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for mapping and navigation during arrhythmia ablation procedures. KODEX-EPD systems are in clinical use at limited sites worldwide. The integrated solution to support cryoablation procedures is intended to be available for sale in the U.S. and Europe in Q4 2019.

For more information: www.usa.philips.com/healthcare, www.medtronic.com

 

References

1. Chugh S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014; 129:837-847.

2. Maurer T, Kuck K-H et al. First clinical experience in high-resolution imaging of left atrial anatomy using a novel wide-band dielectric mapping system. Clin Res Cardiol 108, Suppl 1, April 2019.

Related Content

Biosense Webster Announces Initial Results From First-in-Human QDOT-FAST Study
News | Ablation Systems | May 16, 2019
Johnson & Johnson Medical Devices Companies announced that Biosense Webster, Inc.’s QDot Micro catheter...
CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study
News | Ablation Systems | May 16, 2019
CardioFocus Inc. announced the presentation of results from its pivotal confirmatory study evaluating the HeartLight X3...
New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias
News | Ablation Systems | May 14, 2019
The Heart Rhythm Society (HRS) in partnership with three other professional societies issued an international consensus...
Netherlands Hospital to Install State-of-the-Art MRI Ablation Center
News | Ablation Systems | May 13, 2019
Imricor announced the signing of a commercial agreement with the Haga Hospital in The Hague, Netherlands to outfit a...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Ablation Systems | May 10, 2019 | Dave Fornell, Editor
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
Ablation Reduces Risk of Dementia in Patients With AFib and Carotid Artery Disease
News | Ablation Systems | May 08, 2019
Even though many medical practitioners may opt not to perform procedures on higher-risk patients, new research finds it...
CardioFocus Announces European CE Mark Approval Of HeartLight X3 System
News | Ablation Systems | April 16, 2019
CardioFocus Inc. announced the European CE Mark approval of the HeartLight X3 Endoscopic Ablation System.
First Patient Treated With QDot Micro Ablation Catheter
News | Ablation Systems | February 04, 2019
Biosense Webster has enrolled and treated the first patient in its U.S. Investigational Device Exemption (IDE) study...
FDA Approves TactiCath Contact Force Ablation Catheter, Sensor Enabled
Technology | Ablation Systems | January 21, 2019
Abbott announced U.S. Food and Drug Administration (FDA) approval of the TactiCath Contact Force Ablation Catheter,...
First Patient Treated in STELLAR Atrial Fibrillation IDE Study
News | Ablation Systems | November 30, 2018
Johnson & Johnson Medical Devices Companies announced that Biosense Webster Inc. has enrolled and treated the first...
Overlay Init